On Tuesday, Medtronic revealed it had acquired Sapiens Steering Brain Stimulation, a Dutch company developing brain stimulation technologies, for approximately $200 million in cash.
On Wednesday, the medical device company announced it had acquired NGC Medical S.p.A for $350 million. NGC is an Italian company that manages cardiovascular suites, operating rooms and intensive care units for hospitals.
Additionally, earlier this year, Medtronic acquired Irish device manufacturer Covidien for $42.9 billion.
An Associated Press report suggests the acquisitions of overseas companies are part of an inversion plan that allows the company to pay fewer corporate taxes.
More articles on aquisitions:
What Cerner’s acquisition of Siemens Health Services will mean for the health IT market
Covidien to acquire Reverse Medical
Roche to buy InterMune for $8.3B
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.